MALIGNANT TESTICULAR NEOPLASM
Clinical trials for MALIGNANT TESTICULAR NEOPLASM explained in plain language.
Never miss a new study
Get alerted when new MALIGNANT TESTICULAR NEOPLASM trials appear
Sign up with your email to follow new studies for MALIGNANT TESTICULAR NEOPLASM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for cancer patients with organ failure: early trial combines targeted drug with chemo
Disease control OngoingThis early-phase study tests a drug called veliparib combined with two standard chemotherapy drugs (carboplatin and paclitaxel) in people with advanced solid tumors who also have liver or kidney dysfunction. The main goals are to find the safest dose and understand how the body p…
Matched conditions: MALIGNANT TESTICULAR NEOPLASM
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New PET tracer could reveal hidden cancers
Knowledge-focused OngoingThis early-phase study tests a new imaging agent called 68Ga-FAPI-46, which targets cells around tumors. About 26 adults with various cancers will receive the tracer and then have a PET/CT scan. The goal is to see where the tracer goes in the body and compare it to standard imagi…
Matched conditions: MALIGNANT TESTICULAR NEOPLASM
Phase: PHASE1 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 17, 2026 02:02 UTC